SCHEMBL7265694

SCHEMBL7265694

COCCOC(=O)OC1=C(C)NC(C)=C(c2nc(C)no2)C1c1cccc(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 12/20 0.41
MEN1 O00255 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
KMT2A Q03164 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
THPO P40225 1/20 0.37
ACHE P22303 1/20 0.36
TP53 P04637 2/20 0.35
CACNA1F O60840 1/20 0.34
CACNA1D Q01668 1/20 0.34
CACNA1S Q13698 1/20 0.34
CACNA1C Q13936 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263749 0.90 CACNA1B (0.38) CACNA1BKMT2AMAPTACHETP53
SCHEMBL10995581 0.89 CACNA1B (0.51) CACNA1BMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL7270530 0.87 MEN1 (0.53) CACNA1BMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL7271866 0.85 CYP2C9 (0.46) MEN1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7265650 0.82 ABCC1 (0.32) CYP3A4CYP2C9CYP2C19TSHRCACNA1F
SCHEMBL11002184 0.82 CACNA1B (0.45) CACNA1BMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL7263910 0.81 POLB (0.41) CACNA1BMEN1CYP1A2CYP3A4CYP2C9
SCHEMBL7273183 0.80 HSD17B10 (0.41) KMT2AMAPTTSHR
SCHEMBL7270521 0.80 KMT2A (0.35) MEN1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7271815 0.79 MAPK1 (0.36) MEN1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0116708-A1 Substituted 1,4-dihydropyridines, method for their preparation and their use as pharmaceuticals CASSELLA Aktiengesellschaft (DE) 1984-08-29 EP disclosed